Accendra Health (NYSE:ACH) Lowered to “Hold” Rating by Robert W. Baird

Robert W. Baird lowered shares of Accendra Health (NYSE:ACH) from a strong-buy rating to a hold rating in a research report report published on Tuesday,Zacks.com reports.

Several other equities research analysts also recently issued reports on ACH. Weiss Ratings downgraded shares of Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, August 6th. Zacks Research upgraded shares of Accendra Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 21st. UBS Group increased their price target on shares of Accendra Health from $3.00 to $4.50 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Citigroup lowered shares of Accendra Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $4.50 to $1.50 in a research report on Monday. Four analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $2.50.

Accendra Health Price Performance

ACH opened at $1.24 on Tuesday. The firm has a market cap of $94.96 million, a price-to-earnings ratio of -0.32, a P/E/G ratio of 2.16 and a beta of 1.58. The firm has a 50 day simple moving average of $3.13. Accendra Health has a 12-month low of $1.20 and a 12-month high of $5.85.

Accendra Health (NYSE:ACH) last issued its quarterly earnings results on Monday, August 10th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). Accendra Health had a negative return on equity of 4.24% and a negative net margin of 11.41%.The business had revenue of $613.23 million during the quarter. As a group, equities research analysts expect that Accendra Health will post 0.31 EPS for the current year.

Institutional Trading of Accendra Health

Several institutional investors have recently modified their holdings of the company. Walleye Capital LLC acquired a new position in shares of Accendra Health in the first quarter valued at $27,000. Hsbc Holdings PLC bought a new position in Accendra Health in the first quarter worth $34,000. Abel Hall LLC acquired a new stake in Accendra Health during the first quarter worth $44,000. Keybank National Association OH acquired a new stake in Accendra Health during the first quarter worth $46,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Accendra Health during the first quarter worth $50,000.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.